Gerald W. Both | Chief Scientific Officer
B.Sc, Ph.D (Adel)
Dr Both is a molecular virologist with a career spanning 36 years, largely at CSIRO. He currently has 137 publications and is an inventor on eight PCT patents or patent applications. He is the key inventor on the viral vector patents associated with the OAdV gene delivery technology.
Dr Both has served on Australian Federal Government committees that oversee gene technology and is a regular reviewer for Cancer Gene Therapy. Dr Both is on the editorial board of the international Journal of Gene Medicine and served on the Executive of the Australasian Gene Therapy Society (AGST) since its inception, including four years as President. He was awarded Life Membership of AGST in 2009 for scientific excellence and service.
Dr Both's continuing role will be to formulate scientific strategies and oversee all research and clinical activities of the Company. Part of his responsibilities will be to propose and prepare new intellectual property and participate in its prosecution as well as to assist the interactions with interested commercial parties.

Dr Both joined Broadvector in 2008 and has continued on as Elk's Chief Scientific Officer.